Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.03.22
关于成都深瑞相关事项的公告
2014.03.04
关于控股子公司完成工商变更登记的公告
2014.03.01
关于证券事务代表辞职的公告
2014.02.27
2013年度业绩快报
2014.02.25
关于重大资产重组材料获得中国证监会行政许可申请受理的公告
2014.02.13
关于收到《中国证监会行政许可申请材料补正通知书》的公告
2014.02.12
关于承诺履行情况的公告
2014.02.12
关于监事会换届选举的提示性公告
2014.02.12
关于董事会换届选举的提示性公告
2014.01.29
2014年第一次临时股东大会决议公告
第一页
上一页
117
118
119
120
121
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
